Our study offers novel insights as the first project to link biological consequences of weight loss, namely lower leptin and reduced GLP-1, to eating larger amounts of food, which is a core feature of binge eating, said co-author Lindsay Bodell, a professor in the Department of Psychology at Western University in Ontario, Canada
[PubMed: 16061841] 299
Why the amount of bacteriostatic water matters Reconstitution is not just about dissolving powder

Patient Assessment Protocol Comprehensive medical history with obesity-specific screening Physical examination including BMI, waist circumference, and body composition analysis Laboratory workup: complete metabolic panel, lipid panel, HbA1c, thyroid function, insulin levels Screening for sleep apnea, PCOS, Cushing syndrome, and other secondary causes of obesity Mental health screening for binge eating disorder and depression Readiness-to-change assessment Medication Formulary for Your Medical Weight Loss Program GLP-1 receptor agonists: Semaglutide (Wegovy), liraglutide (Saxenda), tirzepatide (Zepbound) Sympathomimetic agents: Phentermine (short-term), phentermine/topiramate (Qsymia) Other FDA-approved options: Naltrexone/bupropion (Contrave), orlistat (Xenical/Alli) Off-label considerations: Metformin, topiramate, bupropion (when clinically appropriate and properly documented) Your medical weight loss program's protocols should specify prescribing criteria, dosing escalation schedules, monitoring requirements, and discontinuation criteria for each medication

Professional guidance from a GP or HCPC-registered dietitian is recommended before restricting calories if you are under 18, underweight, pregnant, breastfeeding, or managing a medical condition
Hicks et al., 2008